Earnings History Data for Cerus Corporation (CERS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Cerus Corporation

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
03-08-2021	AH	4:00 PM ET (Aug 3)	CERS	Cerus Corporation	862.70	-0.09	-0.10	-0.09	Cerus EPS beats by $0.01, beats on revenue [8/3/2021 4:18 PM]	6.20	1.07 (20.86%)	5.80	0.67 (13.06%)	4.67 - 8.87	9,951,689	1,080,000	358,691
Cerus EPS beats by $0.01, beats on revenue [8/3/2021 4:18 PM] CERS, IDN, ZY and CDLX among after hours movers [8/3/2021 5:42 PM] Cerus Corporation rises after record Q2 revenue and guidance boost [8/4/2021 6:52 AM] Cerus adds Ann Lucena to board of directors [8/4/2021 10:15 AM] Cerus Corporation Announces CMS Has Granted New Technology Add-On Payment for INTERCEPT Fibrinogen Complex [Aug-03-21 06:30AM] Cerus Corporation Announces Record Second Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance [Aug-03-21 04:00PM] Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates [Aug-03-21 05:15PM] Cerus Corporation (CERS) Q2 2021 Earnings Call Transcript [Aug-04-21 05:01AM] What Type Of Shareholders Make Up Cerus Corporation's (NASDAQ:CERS) Share Registry? [Aug-04-21 02:48AM] Cerus Corporation Announces Appointment of Ann Lucena to Board of Directors [Aug-04-21 08:30AM]
04-05-2021	AH	4:00 PM ET (May 4)	CERS	Cerus Corporation	1,020	-0.10	-0.09	-0.10	Cerus EPS in-line, beats on revenue [5/4/2021 4:07 PM]	6.04	0.44 (7.86%)	5.60	0.0 (0.00%)	5.05 - 8.87	2,371,978	1,660,000	100
Cerus EPS in-line, beats on revenue [5/4/2021 4:07 PM] Cerus Corp. to Host Earnings Call [May-04-21 02:30PM] Cerus Corporation Announces First Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance [May-04-21 04:01PM] Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates [May-04-21 05:35PM] Cerus Corporation (CERS) Q1 2021 Earnings Call Transcript [May-05-21 09:30AM]
25-02-2021	AH	4:00 PM ET (Feb 25)	CERS	Cerus Corporation	1,250	-0.09	-0.08	-0.12	Cerus EPS in-line, beats on revenue [2/25/2021 4:12 PM]	6.14	-0.30 (-4.73%)	6.40	-0.05 (-0.78%)	2.71 - 8.87	3,098,931	1,936,233	1,513
Cerus EPS in-line, beats on revenue [2/25/2021 4:12 PM]
29-10-2020	AH	4:00 PM ET (Oct 29)	CERS	Cerus Corporation	990.38	-0.08	-0.12	-0.13	Cerus EPS beats by $0.02, misses on revenue [10/29/2020 4:06 PM]	5.22	-0.33 (-5.94%)	5.50	-0.06 (-0.99%)	2.71 - 7.94	1,623,535	1,287,005	1,259

04-08-2020	AH	4:00 PM ET (Aug 4)	CERS	Cerus Corporation	1,170	-0.09	-0.10	-0.13	Cerus EPS beats by $0.02, beats on revenue [8/4/2020 4:05 PM]	7.23	-0.24 (-3.21%)	7.55	0.08 (1.07%)	2.71 - 7.52	891,730	1,631,590	14,888

05-05-2020	AH	4:00 PM ET (May 5)	CERS	Cerus Corporation	921.43	-0.10	-0.10	-0.14	Cerus EPS in-line, beats on revenue [5/5/2020 4:03 PM]	5.34	0.14 (2.69%)	5.35	0.01 (0.19%)	2.71 - 6.60	2,234,305	1,966,029	8,259